Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria--such as how they synthesise their protective capsules--is essential for developing new ...

Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and ...

Robert Sidbury MD, MPH explored the “long list” of treatment options in atopic dermatitis and how the treatment landscape has changed as a result in a video interview with Healio.“So long list – I ...

Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of ...

The Ensuring Pathways to Innovative Cures Act would extend the time Medicare can negotiate and set prices for small molecule ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial resistance, which the ...

NYU scientists have discovered that cancer cells work together to withstand challenging conditions, revealing new ...

Explore the groundbreaking role of Aspirin and plant-based NSAIDs in tackling inflammation and enhancing overall health.

Sen. Josh Hawley (R-MO) is requesting answers from Dr. Mehmet Oz regarding his prior statements and coverage of transgender ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...